Precision Epigenomics is a molecular diagnostic company that develops molecular diagnostic assays for cancer diagnosis.
Precision Epigenomics has raised $265K in total funding. The most recent round was Debt Financing. The last funding was announced in September 2025.
Precision Epigenomics's investors include National Institutes of Health.
Precision Epigenomics is headquartered in Tucson, United States.
Precision Epigenomics is a molecular diagnostic company that develops molecular diagnostic assays for cancer diagnosis.
Precision Epigenomics is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Precision Epigenomics — Funding & Investors." VCBacked, September 22, 2025, https://www.vcbacked.co/company/precision-epigenomics. Accessed August 13, 2026.
VCBacked. (2025). Precision Epigenomics — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/precision-epigenomics
{{cite web |title=Precision Epigenomics — Funding & Investors |url=https://www.vcbacked.co/company/precision-epigenomics |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated